Are you or a loved one currently in treatment for Flow Therapy? Click here to make your payment online.
Co-Founder and Managing Partner
Trinity Investment Group, LLC
John Wagner was appointed to the Flow Therapy Board of Directors in 2012, and has been a key figure in the development of the organization’s long range planning. Mr. Wagner is co-founder and managing partner of Trinity Investment Group, LLC. Prior to forming Trinity, Mr. Wagner was the CFO of a private equity owned healthcare IT Company, Healthcare Payment Specialists.
Mr. Wagner was a partner with Walker Smith Capital, a long/short equity hedge fund, from 2003 to 2012 where he was responsible for investments within the healthcare industry. Prior to Walker Smith, he worked in the Healthcare Investment Banking Group at UBS as an associate and as an analyst in the Corporate Finance Group at Bank of America. In addition to serving on the Flow Therapy board, Mr. Wagner serves as a Member of the Board of Advanced Plan for Health, and is a member of the Salesmanship Club of Dallas.
John Wagner graduated from the University of Texas with a BBA in Finance.
Medical Director of The Carl and Edyth Lindner Center for Research and Education
The Christ Hospital
Dr. Timothy D. Henry is the Medical Director of The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital in Cincinnati, Ohio. Prior to The Lindner Research Center, he was the Chief of Cardiology at Smidt Heart Institute at Cedars Sinai Medical Center and a Professor of Medicine at Cedars-Sinai and UCLA from 2013 to 2018 and the Director of Research at the Minneapolis Heart Institute Foundation, at Abbott Northwestern Hospital in Minneapolis and a Professor of Medicine at the University of Minneapolis from 2001 to 2013.
He has published over 600 manuscripts and book chapters and has served as principal investigator and steering committees of multiple large, multicenter research trials in acute myocardial infarction, refractory angina and regenerative medicine with gene and stem cell therapy. He is Principle Investigator for 2 large STEMI registries, The Midwest STEMI Consortium and the North American COVID STEMI registry. Among other awards, Henry has been named to the Best Doctors in America list each year for the last 15 years, became a Master Fellow for the Society for Cardiovascular Angiography and Interventions (SCAI) in 2015, received the American Heart Association’s Heart and Stroke Hero Award in Research in 2013, the LUMEN Global Lifetime Achievement Award in MI in 2012, and most recently was awarded the Cincinnati 2021 Health Care Heroes Award, Innovator. He is currently the President of The Society for Cardiovascular Angiography and Interventions (SCAI) (2021-2022).
Former Chief Executive Officer
Triad Hospitals
James D. Shelton joined the Flow Therapy board in 2013, having served and shaped the healthcare industry throughout his thirty-year career. From 1998 through 2007, Mr. Shelton served as the Chairman and CEO of Triad Hospitals, taking the company from its initial formation to a position as the third largest healthcare provider in the US, prior to its sale in 2007.
Prior to Triad Hospitals, Mr. Shelton was President of the Central Group of Columbia/HCA, where he had responsibility for 107 hospitals and 45 ambulatory surgery centers between 1993 and 1998. Beginning in 1986, Mr. Shelton served as a hospital administrator in multiple different states and was both Senior Vice President and Executive Vice President at National Medical Enterprises.
Mr. Shelton served on the Board of the Federation of American Hospitals for ten years (1991-2001) and as its Chairman in 1999. He served a three-year term on the Board of the American Hospital Association (2004-2006), during which he was a member of the executive committee. From 2001 through 2006 and again in 2008, he was recognized by Modern Healthcare as one of the 100 most influential people in healthcare in America.
In addition to his role on the , Mr. Shelton serves on the boards of three publicly traded companies—Omnicare, Inc. (NYSE: OCR), Ventas (NYSE: VTR), and Envision (NYSE: EVHC). At Omnicare, Mr. Shelton serves as the Chairman of the Board. He is also the Board Chairman of the Four Corners Global Outreach project, and serves as a senior advisor to CCMP, a private equity firm in New York.
A native of Shreveport, Louisiana, James D. Shelton received his B.A. in history from LSU in 1975 and an M.S. from the Graduate School of Public Administration (now the Harry S. Truman School of Public Affairs) at the University of Missouri, Columbia in 1977. In 2005, he was inducted into the LSU Alumni Hall of Distinction.
Founder and President, Chairman
Flow Therapy, LLC
Michael Gratch founded Flow Therapy (previously known as Legacy Heart Care) in 2003, in response to a recognized need for broader availability of a non-invasive treatment to the chronic ischemic population. Through his guidance and leadership, Flow Therapy has grown to be the nation’s largest provider of EECP treatments, as well as the recognized leader in quality. Michael served as an Executive Vice President at PhysAssist Scribe from 2010 through 2011. He was recognized as one of North Texas’ “40 under 40” in 2006 and has also been an active member of YPO since 2013.
Michael graduated from Dartmouth College in 2002 and earned All-Ivy League recognition on the football team.
